Barinthus Biotherapeutics plc (BRNS) — Cash Flow Reinvestment Rate
Latest as of December 2024:
0.04x
Barinthus Biotherapeutics plc (BRNS) has a Cash Flow Reinvestment Rate of 0.04x as of December 2024, reinvesting $556.00K (capex $278.00K plus investments $-278.00K) from operating cash flow of $13.09 Million. See free cash flow generation of Barinthus Biotherapeutics plc to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.04x
(Capex + Investments) / Operating CF
Total Reinvested
$556.00K
Capex + Investments
Operating Cash Flow
$13.09 Million
USD
Capital Expenditures
$278.00K
USD
Annual Cash Flow Reinvestment Rate for Barinthus Biotherapeutics plc (None–None)
Year-by-year capital reinvestment analysis for Barinthus Biotherapeutics plc. See Barinthus Biotherapeutics plc (BRNS) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow